Researcher profile

Stefan Neubauer

Stefan Neubauer is a Professor of Cardiovascular Medicine, Head of the Division of Cardiovascular Medicine and Director of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, John Radcliffe Hospital, United Kingdom. Prof. Neubauer’s work over the past 35 years has been devoted to the development and application of Cardiovascular Magnetic Resonance (CMR) imaging and spectroscopy, and, in recent years, also to the development of novel liver and multiorgan MR imaging as well as novel coronary CT imaging. He has attracted over £220M in research funding, has published >690 original research articles (Scopus h-index = 106), and currently leads a group of ~60 co-workers. He has supervised over 100 PhD/MD students, who have won >40 young investigator awards. Editorial positions and contributions to scientific bodies include his involvement with the Society for Cardiovascular Magnetic Resonance (President 2006-2007), Chairman of the British Society of Cardiovascular Magnetic Resonance (2008-2010), International Associate Editor of the European Heart Journal (2010-2020), Associate Editor of the Journal of Cardiovascular Magnetic Resonance. Awards and Honours include the American Heart Association Paul Dudley White International Lectureship Award 2005, the British Cardiovascular Society Thomas Lewis Lecture 2008, National Institute for Health Research Senior Investigator Award 2010, the European Magnetic Resonance Award 2010, the SCMR Gold Medal 2013, the RT Hall Lecture 2017, the German Cardiac Society Honorary Award Lecture on Clinical Science 2020, the European Society of Cardiology Paul Hugenholtz Innovation Lecture 2022 and the European Society of Cardiology Silver Medal 2022. He is a fellow of the UK Academy of Medical Sciences. He has been the leader of the Imaging Theme for the Oxford NIHR Biomedical Research Centre since 2017. He is also a founder, and was (2012-2019) CMO of Perspectum, a biomedical imaging biotech company, and is a founder and non-executive director of Caristo Diagnostics (since 2018), a cardiac CT spinout company.